Willingness to Participate in Alzheimer Disease Research and Attitudes Towards Proxy-Informed Consent: Results From the Health and Retirement Study

被引:15
作者
Ayalon, Liat [1 ]
机构
[1] Bar Ilan Univ, Sch Social Work, IL-52900 Ramat Gan, Israel
关键词
Dementia; ethics; caregiving; decision-making; informed-consent; CLINICAL-RESEARCH; SURROGATE CONSENT; DEMENTIA; CAPACITY; RISK; COMPETENCE; PREVALENCE; STANDARDS; VIEWS;
D O I
10.1097/JGP.0b013e31818cd3d3
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Objectives: To evaluate public opinion about participation in Alzheimer disease (AD) research and willingness to have a proxy-informed consent. Design: Cross-sectional. Setting: A national survey of community-dwelling adult; over The age of 50 and their spouse of any age. Participants: The 2006 wave of the Health and Retirement Study, (N = 1,517). Measurements: Willingness to participate in one of four possible research scenarios and to have a proxy-informed consent for AD research. Results: Overall, 65.8% agreed to participate in AD research and 70.7% agreed to proxy-informed consent. Relative to a minimal benefit and moderate risk scenario, participants were more likely to favor participation in a moderate benefit and minimal risk scenario and less likely to endorse a minimal benefit and severe risk scenario. Those agreeing to participate in The study were more likely to agree to proxy consent and to give leeway to a research pro:91 to go against their will. Conclusions: Most participants view AD research favorably and arc, agreeable toward participating in such research as well as toward having a research proxy. Participants are able to distinguish between studies of different levels of benefit and risk. Nevertheless, over 50% agreed to a study of minimal benefit and severe risk. Researchers and clinicians should be aware that those less agreeable toward AD research are less interested in having a research proxy. (Am J Geriatr Psychiatry 2009; 17:65-74)
引用
收藏
页码:65 / 74
页数:10
相关论文
共 30 条
[1]  
[Anonymous], 2000, DOCUMENTATION AFFECT
[2]  
Beauchamp T. L., 2001, Principles of Biomedical Ethics
[3]  
Bravo G., 2003, Dementia, V2, P49
[4]   Predicting caregiver burden and depression in Alzheimer's disease [J].
Clyburn, LD ;
Stones, MJ ;
Hadjistavropoulos, T ;
Tuokko, H .
JOURNALS OF GERONTOLOGY SERIES B-PSYCHOLOGICAL SCIENCES AND SOCIAL SCIENCES, 2000, 55 (01) :S2-S13
[5]   Assessing decisional capacity for clinical research or treatment: A review of instruments [J].
Dunn, Laura B. ;
Nowrangi, Milap A. ;
Palmer, Barton W. ;
Jeste, Dilip V. ;
Saks, Elyn R. .
AMERICAN JOURNAL OF PSYCHIATRY, 2006, 163 (08) :1323-1334
[6]   Phase 2 safety trial targeting amyloid β production with a γ-secretase inhibitor in Alzheimer disease [J].
Fleisher, Adam S. ;
Raman, Rema ;
Siemers, Eric R. ;
Becerra, Lida ;
Clark, Christopher M. ;
Dean, Robert A. ;
Farlow, Martin R. ;
Galvin, James E. ;
Peskind, Elaine R. ;
Quinn, Joseph F. ;
Sherzai, Abdullah ;
Sowell, Brooke ;
Aisen, Paul S. ;
Thal, Leon J. .
ARCHIVES OF NEUROLOGY, 2008, 65 (08) :1031-1038
[7]  
FOLSTEIN MF, 1975, J PSYCHIATR RES, V12, P198
[8]   Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics [J].
Hardy, J ;
Selkoe, DJ .
SCIENCE, 2002, 297 (5580) :353-356
[9]   Alzheimer disease in the US population - Prevalence estimates using the 2000 census [J].
Hebert, LE ;
Scherr, PA ;
Bienias, JL ;
Bennett, DA ;
Evans, DA .
ARCHIVES OF NEUROLOGY, 2003, 60 (08) :1119-1122
[10]  
Hosmer W., 2000, Applied Logistic Regression, VSecond